1型糖尿病高危亲属诊断前C肽水平的遗传关联
该研究对TrialNet Pathway to Prevention研究中713例自身抗体阳性且最终发展为1型糖尿病的参与者进行回顾性分析,评估16个已知单核苷酸多态性及1型糖尿病遗传风险评分2(T1D-GRS2)与诊断前9个月内口服葡萄糖耐量试验C肽曲线下面积(AUC)的关系。结果显示,较高的T1D-GRS2及2型糖尿病相关JAZF1 rs864745 T等位基因与诊断前较低的C肽AUC相关,对预防试验设计有启示。
要点
- 较高T1D-GRS2与诊断前9个月内C肽AUC较低相关(多变量β=-.03,P=.005)。
- 携带JAZF1 rs864745 T等位基因者C肽AUC较低(多变量β=-.06,P=.018)。
- 上述遗传关联对1型糖尿病预防试验设计有启示。
核心结论
- 2型糖尿病相关JAZF1 rs864745 T等位基因和较高T1D-GRS2与1型糖尿病诊断前较低的C肽AUC相关,对预防试验设计有启示。
研究设计与样本
- 对TrialNet Pathway to Prevention研究中713例自身抗体阳性且发展为1型糖尿病、具有T1DExomeChip数据的参与者进行回顾性分析。
主要发现
- 较高T1D-GRS2与诊断前9个月内C肽AUC较低相关,单变量分析β=-.06(P<.0001),多变量分析β=-.03(P=.005)。
- 携带JAZF1 rs864745 T等位基因的参与者C肽AUC较低,单变量分析β=-.11(P=.002),多变量分析β=-.06(P=.018)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We sought to determine whether the type 1 diabetes genetic risk score-2 (T1D-GRS2) and single nucleotide polymorphisms are associated with C-peptide preservation before type 1 diabetes diagnosis. METHODS: We conducted a retrospective analysis of 713 autoantibody-positive participants who developed type 1 diabetes in the TrialNet Pathway to Prevention Study who had T1DExomeChip data. We evaluated the relationships of 16 known single nucleotide polymorphisms and T1D-GRS2 with area under the curve (AUC) C-peptide levels during oral glucose tolerance tests conducted in the 9 months before diagnosis. RESULTS: Higher T1D-GRS2 was associated with lower C-peptide AUC in the 9 months before diagnosis in univariate (β = -.06, P < .0001) and multivariate (β = -.03, P = .005) analyses. Participants with the JAZF1 rs864745 T allele had lower C-peptide AUC in both univariate (β = -.11, P = .002) and multivariate (β = -.06, P = .018) analyses. CONCLUSION: The type 2 diabetes-associated JAZF1 rs864745 T allele and higher T1D-GRS2 are associated with lower C-peptide AUC before diagnosis of type 1 diabetes, with implications for the design of prevention trials.
引用
- Triolo TM, Parikh HM, Tosur M, et al. Genetic Associations With C-peptide Levels Before Type 1 Diabetes Diagnosis in At-risk Relatives. J Clin Endocrinol Metab. 2025. PMID: 38767115. doi:10.1210/clinem/dgae349
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。